BrEPEM-LH-22017
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BrEPEM-LH-22017, covering 2024-02-26 to 2024-02-26. Get the full timeline:
Most recent: Clinical Trial Update: BrEPEM-LH-22017 for Older Patients With Untreated Hodgkin Lymphoma (HL) [Phase 1, Phase 2]